An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
Clinical trial NCT03459222 · COMPLETED
Trial details
- NCT number
- NCT03459222
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2025-02-19
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.